Dasatinib for imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia_database INFINITY_data_export

Zackova, Daniela, University Hospital Brno, https://orcid.org/0000-0001-9802-8148

Minarik, Radek, University Hospital Brno

Kristkova, Zlatuse, Institute of biostatistics and analyses, Ltd., Brno

zackova.daniela@fnbrno.cz, minarik.radek@fnbrno.cz, kristkova@biostatistika.cz

Published Feb 20, 2020 on Dryad. https://doi.org/10.5061/dryad.vhhmgqnqd

Cite this dataset

Zackova, Daniela; Minarik, Radek; Kristkova, Zlatuse (2020). Dasatinib for imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia_database INFINITY_data_export [Dataset]. Dryad. https://doi.org/10.5061/dryad.vhhmgqnqd

Abstract

To compare long-term real-life results of dasatinib therapy to clinical trial data among chronic phase chronic myeloid leukemia patients resistant or intolerant to imatinib, we retrospectively analysed data of 118 patients treated in centres participating in the database INFINITY. Presented dataset was prepared as a data export from INFINITY database, comprehensive Czech database of patients with chronic myeloid leukemia treated in participated specialised hematological centers in the Czech Republic.